Brighton Jones LLC Ligand Pharmaceuticals Inc Transaction History

Brighton Jones LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$113.03 - $155.64 $169,545 - $233,459	-1,500 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$99.52 - $215.83 $149,280 - $323,745	1,500 New	1,500 $229,000
Q3 2020 Nov 12, 2020	SELL	$89.56 - $126.72 $179,120 - $253,440	-2,000 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$68.28 - $123.65 $136,560 - $247,300	2,000 New	2,000 $224,000

276

18.5M

30.8K

5.2K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.85B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Brighton Jones LLC, based on Form 13F filings with the SEC.

Stay updated on Brighton Jones LLC with notifications on news.